The search found 2 results in 0.106 seconds.
Recent comments by Australian negotiators indicate that the US is seeking changes to Australia's intellectual property laws, particularly as they relate to pharmaceuticals. Such changes have the capacity to undermine the effectiveness of the pharmaceutical benefits scheme and lead to higher costs in Australia. Buddhima...
This paper considers the likely impact of reforms sought by the US pharmaceutical companies on the PBS system in Australia. The PBS system is currently effective in minimising the price paid by Australians to US pharmaceutical companies. If these price controls were relaxed it is...